Teva Sued Over Generic HIV Drug

Law360, New York (August 8, 2011, 7:21 PM EDT) -- ViiV Healthcare Co., a joint venture of GlaxoSmithKline PLC and Pfizer Inc., filed a patent infringement suit against Teva Pharmaceutical Industries Ltd. on Monday in Delaware federal court to stop Teva from making a generic version of HIV drug Epzicom.

ViiV is asking the court to issue an order blocking Israel-based Teva from making a generic version of Epzicom, also known as Kivexa. Teva's proposed generic will infringe a U.S. patent ViiV obtained in 2002, the suit claims.

“ViiV will be irreparably harmed by Teva's infringing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.